| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $495K | — | +68.9% |
| Cost of Revenue | $46K | — | — |
| Gross Profit | $449K | — | +53.2% |
| R&D Expense | $2.3M | — | -3.6% |
| SG&A Expense | $1.7M | — | +1.4% |
| Operating Income | -$3.6M | — | +5.7% |
| Pre-tax Income | -$3.5M | — | +6.7% |
| Income Tax | $3K | — | +0.0% |
| Net Income | -$3.5M | — | +6.7% |
| EPS (Basic) | -$0.90 | — | -104.5% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Accounts Receivable | $179K | -24.5% | +62.7% |
| Inventory | $57K | -13.6% | +29.5% |
| Current Assets | $10.8M | -20.7% | +58.7% |
| Total Assets | $11.3M | -20.4% | +48.3% |
| Current Liabilities | $3.9M | +5.5% | -43.9% |
| Total Liabilities | $3.9M | +5.5% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$2.8M | — | -4.0% |
| Financing Cash Flow | $129K | — | -97.9% |
| -43.9% |
| Stockholders' Equity | $7.3M | -29.8% | +1194.7% |